Development and Validation of a Diagnostic Histopathological Scoring System for Capsular Contracture Based on 720 Breast Implant Capsules
Entwicklung und Validierung eines diagnostischen histopathologischen Scoring-Systems für Kapselkontraktur auf Basis von 720 Brustimplantatkapseln
Aesthetic Surgery Journal · 15.05.2024 · 44 (6) · NP391-NP401
DOI: 10.1093/asj/sjae050 ↗Auf einen Blick
Es wurden histopathologische Scoring-Systeme zur Schweregradbeurteilung der Kapselkontraktur entwickelt und validiert. Die Validierung zeigte für die Augmentations- und Rekonstruktionsscores eine gute bis starke Leistung.
Fragestellung
Entwicklung und Validierung procedure-spezifischer histopathologischer Scoring-Systeme zur Beurteilung der Schwere der Kapselkontraktur.
Methode
Brustimplantatkapsel-Biopsien zur Entwicklung von Scoring-Systemen nach Augmentation und Rekonstruktion; 10 histologische Parameter per multivariabler logistischer Regression geprüft; Validierung mit AUC und MAE.
Ergebnisse
720 Biopsien von 542 Patient:innen. Augmentationsscore: 4 Parameter, Maximalscore 26, AUC 81 % und MAE 0,8 %. Rekonstruktionsscore: 3 Parameter, Maximalscore 19, AUC 72 % und MAE 7,1 %.
Schlussfolgerung der Autor:innen
Die neuen histopathologischen Scoring-Systeme ermöglichen laut Autor:innen eine objektive, reproduzierbare und genaue Beurteilung der Schwere der Kapselkontraktur.
Kernaussagen
- 720 Biopsien von 542 Patient:innen wurden ausgewertet
- Augmentationsscore: 4 Parameter, Maximalscore 26, AUC 81 %
- Rekonstruktionsscore: 3 Parameter, Maximalscore 19, AUC 72 %
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Validierungsstudie in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 01.03.2024. Verfasst von Andreas Larsen und 14 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Implants, Implant Capsular Contracture, Breast Implantation, Severity of Illness Index. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Research Fund of Rigshospitalet, Novo Nordisk Foundation, the Capitol Region of Denmark Research Fund.
Themen: Kontrakturprophylaxe
Abstract (Originalsprache)
Background
Capsular contracture is traditionally evaluated with the Baker classification, but this has notable limitations regarding reproducibility and objectivity.
Objectives
The aim of this study was to develop and validate procedure-specific histopathological scoring systems to assess capsular contracture severity.
Methods
Biopsies of breast implant capsules were used to develop histopathological scoring systems for patients following breast augmentation and breast reconstruction. Ten histological parameters were evaluated by multivariable logistic regression to identify those most associated with capsular contracture. Significant parameters (P < .05) were selected for the scoring systems and assigned weighted scores (1-10). Validation was assessed from the area under the curve (AUC) and the mean absolute error (MAE).
Results
A total of 720 biopsies from 542 patients were included. Four parameters were selected for the augmentation scoring system, namely, collagen layer thickness, fiber organization, inflammatory infiltration, and calcification, providing a combined maximum score of 26. The AUC and MAE for the augmentation scoring system were 81% and 0.8%, which is considered strong. Three parameters were selected for the reconstruction scoring system, namely, fiber organization, collagen layer cellularity, and inflammatory infiltration, providing a combined maximum score of 19. The AUC and MAE of the reconstruction scoring system were 72% and 7.1%, which is considered good.
Conclusions
The new histopathological scoring systems provide an objective, reproducible, and accurate assessment of capsular contracture severity. We propose these novel scoring systems as a valuable tool for confirming capsular contracture diagnosis in the clinical setting, for research, and for implant manufacturers and insurance providers in need of a confirmed capsular contracture diagnosis. Level of Evidence: 3
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- Research Fund of Rigshospitalet
- Novo Nordisk Foundation
- the Capitol Region of Denmark Research Fund
Zitieren
APA
Larsen, A., Timmermann, A. M., Kring, M., Mathisen, S. B., Bak, E. E. F., Weltz, T. K., Ørholt, M., Vester-Glowinski, P., Elberg, J. J., Trillingsgaard, J., Mielke, L. V., Hölmich, L. R., Damsgaard, T. E., Roslind, A., & Herly, M. (2024). Development and Validation of a Diagnostic Histopathological Scoring System for Capsular Contracture Based on 720 Breast Implant Capsules. Aesthetic Surgery Journal, 44(6), NP391-NP401. https://doi.org/10.1093/asj/sjae050
Vancouver
Larsen A, Timmermann AM, Kring M, Mathisen SB, Bak EEF, Weltz TK, et al. Development and Validation of a Diagnostic Histopathological Scoring System for Capsular Contracture Based on 720 Breast Implant Capsules. Aesthetic Surgery Journal. 2024;44(6):NP391-NP401. doi:10.1093/asj/sjae050
BibTeX
@article{Larsen2024,
author = {Larsen, Andreas and Timmermann, Adam Mandrup and Kring, Mikela and Mathisen, Sif Birch and Bak, Erik Eiler Frydshou and Weltz, Tim Kongsmark and Ørholt, Mathias and Vester-Glowinski, Peter and Elberg, Jens Jørgen and Trillingsgaard, Jesper and Mielke, Louise Vennegaard and Hölmich, Lisbet Rosenkrantz and Damsgaard, Tine Engberg and Roslind, Anne and Herly, Mikkel},
title = {Development and Validation of a Diagnostic Histopathological Scoring System for Capsular Contracture Based on 720 Breast Implant Capsules},
journal = {Aesthetic Surgery Journal},
year = {2024},
volume = {44},
number = {6},
pages = {NP391--NP401},
doi = {10.1093/asj/sjae050}
}
EUVIMED